(Reuters) - A U.S. antitrust regulator said on Tuesday it will sue to stop Amgen (NASDAQ:AMGN)'s $27.8 billion deal for Horizon Therapeutics (NASDAQ:HZNP) Plc, as it would give Amgen "monopoly positions" in treatments for thyroid eye disease and chronic refractory gout.
Here is a list of some mergers that recently faced strong antitrust scrutiny around the world:
DEALS UNDER SCRUTINY
DEAL DEAL VALUE CONTEXT
Amgen-Horizon $27.8 The U.S. FTC sued to block Amgen
Therapeutics billion Inc's $27.8 billion deal to buy
Horizon Therapeutics over
competition concerns in the
thyroid eye disease and gout
treatment markets.
Microsoft (NASDAQ:MSFT) - $69 billion The European antitrust body
Activision cleared Microsoft's purchase of
Blizzard Activision, in a significant
boost that could prompt Chinese
and South Korean regulators to
follow suit despite a British
veto of the deal.
Broadcom (NASDAQ:AVGO) - $61 billion The European Commission has
VMware (NYSE:VMW) informed Broadcom of its
objection that the deal could
restrict global competition for
the supply of certain adapters by
limiting access for competitors'
hardware to VMware's software.
Intercontinent $13.1 The U.S. FTC said it would seek
al Exchange - billion to stop the deal as it may lead
Black Knight (NYSE:BKI) to higher fees, less innovation
and fewer choices in the
financing process for home
purchases.
Amazon.com (NASDAQ:AMZN) - $1.7 Britain's competition regulator
iRobot (NASDAQ:IRBT) billion launched a "Phase 1" probe into
Amazon.com's planned acquisition
of iRobot. The deal is also being
reviewed by the U.S. FTC.
Kroger (NYSE:KR) - $25 billion Kroger has asked a U.S. judge to
Albertsons dismiss as "speculative" a
Companies consumer antitrust lawsuit
alleging the merger would lessen
grocer competition and drive up
prices.
JetBlue-Spirit $3.8 California and three other states
billion joined the U.S. Justice
Department lawsuit aimed at
preventing JetBlue Airways (NASDAQ:JBLU) from
buying rival discount carrier
Spirit Airlines (NYSE:SAVE).
Illumina (NASDAQ:ILMN) - $7.1 FTC ordered Illumina to divest
Grail billion cancer diagnostic test maker
Grail, finding that its ownership
would stifle competition in the
U.S. market for cancer tests.
DEALS BLOCKED OR ABANDONED
DEAL DEAL VALUE CONTEXT
Voyager Digital - $1.3 Binance.US called off its deal
Binance.US billion to buy assets of bankrupt
crypto lender Voyager Digital,
citing a "hostile and uncertain
regulatory climate."
Nvidia (NASDAQ:NVDA) Corp - Arm More than SoftBank Group Corp shelved its
$80 blockbuster sale of Arm Ltd to
billion the U.S. chipmaker. The FTC
argued that competition in the
nascent markets for chips in
self-driving cars and a new
category of networking chips
could be hurt.
Penguin Random $2.2 Penguin owner Bertelsmann
House - Simon & billion scrapped the merger in
Schuster November. The Biden
administration said the deal
should be stopped because it
would lead to less competition
for blockbuster books and lower
advances for authors who earn
$250,000 or more.
DEALS THAT WENT THROUGH
DEAL DEAL VALUE CONTEXT
Rogers (NYSE:ROG) C$20 The final nod from Minister of
Communication - billion Innovation, Science and
Shaw Industry Francois-Philippe
Communication Champagne capped two years of
antitrust uncertainty.
Meta Platforms - Unknown The FTC, which lost a fight in
Within court to block the
acquisition, said in a filing
that it has decided to
formally end its effort.
UnitedHealth (NYSE:UNH) About $8 The deal's completion follows
Group - Change billion a U.S. judge denying the
Healthcare Justice department's bid to
stop it. The DoJ had said
access to the target's claims
would give UnitedHealth a view
into rivals' health plans.